# Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance), Division 2.2.3: Vaccination

Extent: E+W+S+N.I.

Attenuated viruses or bacteria
4 weeks
Inactivated/killed viruses, bacteria or rickettsiae
No deferral if well
Toxoids
No deferral if well
Hepatitis A or hepatitis B vaccines
No deferral if well and if no exposure
Rabies
No deferral if well and if no exposure
If vaccination is given following exposure defer for one year
Tick-borne encephalitis vaccines
No deferral if well and if no exposure

---
Source: https://www.legislation.gov.uk/eudr/2004/33/annex/III/division/2/division/2.2/division/2.2.3 (the official version)
Page: https://openlegislation.uk/eu-directive-2004-33/annex-III/division-2/division-2.2/division-2.2.3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

